Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC

Infection, Genetics and Evolution

Volumn 12, Issue 2, 2012, Pages 236-239

  Jahan, Shah ^a   Ashfaq, Usman A ^b   Khaliq, Saba ^a   Samreen, Baila ^a   Afzal, Nadeem ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Apoptosis; Cell proliferation; HCC; HCV; HCV Core gene

Indexed keywords

CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CORE PROTEIN; CYTOKERATIN 18; HEPATITIS C VIRUS CORE PROTEIN; NONSTRUCTURAL PROTEIN 5B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CELL PROLIFERATION; CHRONIC HEPATITIS; GENE CONTROL; GENE FUNCTION; GENETIC HETEROGENEITY; GENOTYPE; HCV CORE GENE; HUMAN; IMMUNE RESPONSE; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; VIRUS GENE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 84857640803     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.01.006     Document Type: Review

References (38)

1. Alter M.J. Epidemiology of hepatitis C. Hepatology 1997, 26:62S-65S.
2. Bantel H., Lugering A., Poremba C., Lugering N., Held J., Domschke W., Schulze-Osthoff K. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 2001, 34:758-767.
3. Bantel H., Ruck P., Gregor M., Schulze-Osthoff K. Detection of elevated caspase activation and early apoptosis in liver diseases. Eur. J. Cell Biol. 2001, 80:230-239.
4. Bantel H., Schulze-Osthoff K. Apoptosis in hepatitis C virus infection. Cell Death Differ. 2003, 10(Suppl 1):S48-S58.
5. Bartenschlager R. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. Curr. Opin. Microbiol. 2006, 9:416-422.
6. Calabrese F., Pontisso P., Pettenazzo E., Benvegnu L., Vario A., Chemello L., Alberti A., Valente M. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 2000, 31:1153-1159.
7. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 1991, 88:2451-2455.
8. Chou A.H., Tsai H.F., Wu Y.Y., Hu C.Y., Hwang L.H., Hsu P.I., Hsu P.N. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 2005, 174:2160-2166.
9. Downward J. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 2004, 15:177-182.
10. Dustin L.B., Rice C.M. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 2007, 25:71-99.
11. Fischer R., Baumert T., Blum H.E. Hepatitis C virus infection and apoptosis. World J. Gastroenterol. 2007, 13:4865-4872.
12. Fuentes-Prior P., Salvesen G.S. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 2004, 384:201-232.
13. Guicciardi M.E., Gores G.J. Apoptosis as a mechanism for liver disease progression. Semin. Liver Dis. 2010, 30:402-410.
14. Hoofnagle J.H. Course and outcome of hepatitis C. Hepatology 2002, 36:S21-29.
15. Idrees M., Rafique S., Rehman I., Akbar H., Yousaf M.Z., Butt S., Awan Z., Manzoor S., Akram M., Aftab M., Khubaib B., Riazuddin S. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World J. Gastroenterol. 2009, 15:5080-5085.
16. Jahan S., Khaliq S., Ijaz B., Ahmad W., Hassan S. Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virol. J. 2011, 8:155.
17. Kao C.F., Chen S.Y., Chen J.Y., Wu Lee Y.H. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 2004, 23:2472-2483.
18. Khan U.R., Janjua N.Z., Akhtar S., Hatcher J. Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Tropical Med. Int. Health 2008, 13:754-761.
19. Lin C., Lindenbach B.D., Pragai B.M., McCourt D.W., Rice C.M. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 1994, 68:5063-5073.
20. Machida K., Tsukiyama-Kohara K., Seike E., Tone S., Shibasaki F., Shimizu M., Takahashi H., Hayashi Y., Funata N., Taya C., Yonekawa H., Kohara M. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J. Biol. Chem. 2001, 276:12140-12146.
21. Malhi H., Gores G.J. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008, 134:1641-1654.
22. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4:1065-1067.
23. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., Koike K. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001, 61:4365-4370.
24. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
25. Nishizono A., Hiraga M., Mifune K., Terao H., Fujioka T., Nasu M., Goto T., Misumi J., Moriyama M., Arakawa Y., et al. Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by Western blot (immunoblot) analysis using a recombinant vaccinia virus expression system. J. Clin. Microbiol. 1993, 31:1173-1178.
26. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
27. Otsuka M., Kato N., Lan K., Yoshida H., Kato J., Goto T., Shiratori Y., Omata M. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 2000, 275:34122-34130.
28. Otsuka M., Kato N., Taniguchi H., Yoshida H., Goto T., Shiratori Y., Omata M. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Virology 2002, 296:84-93.
29. Pavio N., Lai M.M. The hepatitis C virus persistence: how to evade the immune system?. J. Biosci. 2003, 28:287-304.
30. Porter G.A., Jänicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999, 6:99-104.
31. Raja N.S. Epidemiology of hepatitis C virus infection in Pakistan. J. Microbiol. Immunol. Infect. 2008, 41:4-8.
32. Ray R.B., Meyer K., Steele R., Shrivastava A., Aggarwal B.B., Ray R. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 1998, 273:2256-2259.
33. Raza S.A., Clifford G.M., Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br. J. Cancer 2007, 96:1127-1134.
34. Reed K.E., Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 2000, 242:55-84.
35. Rouquet N., Carlier K., Briand P., Wiels J., Joulin V. Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem. Biophys. Res. Commun. 1996, 229:27-35.
36. Ruggieri A., Harada T., Matsuura Y., Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 1997, 229:68-76.
37. Saito K., Meyer K., Warner R., Basu A., Ray R.B., Ray R. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J. Virol. 2006, 80:4372-4379.
38. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K.B., Goncharov T., Holtmann H., Lonai P., Wallach D. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9:267-276.